Abstract 12135: Quality of Life in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
Year: 2023
Type: conference-abstract
Source: Circulation
Authors: Catherine G Ireland, Sharlene Day, Anna Axelsson, Mark W Russell, Kenneth G Zahka, Alexandre Pereira, Charles E Canter, Richard G Bach, Matthew T Wheeler, Joseph W Rossano, Anjali T Owens, Henning Bundgaard, Luisa Mestroni, Matthew R Taylor, Patel R Amit, Ivan Wilmot, Jonathan H Soslow, Jason R Becker, Endel J Orav, Carolyn Y Ho
Institutions: Brigham and Women's Hospital, Harvard University, University of Pennsylvania, Rigshospitalet, University of Michigan, Cleveland Clinic, Universidade de São Paulo, Instituto do Coração - HCFMUSP, Washington University in St. Louis, Stanford Medicine, Stanford University, Children's Hospital of Philadelphia, University of Colorado Anschutz, University of Chicago, Cincinnati Children's Hospital Medical Center, Vanderbilt University Medical Center, University of Pittsburgh
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389953406
